Randomized controlled trial of standard versus high-dose intravenous omeprazole after endoscopic therapy in high-risk patients with acute peptic ulcer bleeding

2011 ◽  
Vol 98 (5) ◽  
pp. 640-644 ◽  
Author(s):  
W. H. Chan ◽  
L. W. Khin ◽  
Y. F. A. Chung ◽  
Y. C. Goh ◽  
H. S. Ong ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Peptic Ulcer ◽  
High Risk ◽  
Endoscopic Therapy ◽  
Controlled Trial ◽  
Ulcer Bleeding ◽  
High Dose ◽  
Peptic Ulcer Bleeding ◽  
Randomized Controlled ◽  
Risk Patients

scholarly journals A randomized controlled trial comparing two different dosages of infusional pantoprazole in peptic ulcer bleeding

2010 ◽  
Vol 69 (3) ◽  
pp. 245-251 ◽  
Author(s):  
Yao-Chun Hsu ◽  
Chin-Lin Perng ◽  
Tzeng-Huey Yang ◽  
Chaur-Shine Wang ◽  
Wei-Lun Hsu ◽  
...  
Keyword(s):  
Randomized Controlled Trial ◽  
Peptic Ulcer ◽  
Controlled Trial ◽  
Ulcer Bleeding ◽  
Peptic Ulcer Bleeding ◽  
Randomized Controlled

UPDATE ON ENDOSCOPIC MANAGEMENT OF PEPTIC ULCER BLEEDING

2012 ◽  
pp. 5-11
Author(s):  
Ngoc Quy Hue Dang ◽  
Van Huy Tran
Keyword(s):  
Peptic Ulcer ◽  
High Risk ◽  
Proton Pump Inhibitors ◽  
Proton Pump ◽  
Endoscopic Therapy ◽  
Active Bleeding ◽  
Ulcer Bleeding ◽  
Endoscopic Management ◽  
High Dose ◽  
Peptic Ulcer Bleeding

Peptic ulcer bleeding is a common medical emergency and still a potentially fatal condition. It is the best managed using a multidisciplinary approach by a team with medical, endoscopic and surgical expertise. Appropriate resuscitation followed by early endoscopy for diagnosis and treatment are of major importance in these patients. Endoscopy is recommended within 24 h of presentation. Endoscopic therapy is indicated for patients with high-risk stigmata, in particular those with active bleeding and visible vessels. A combination of proton pump inhibitors and endoscopic therapy (using a combination of injection and mechanical hemostasis) offers the best chance of hemostasis for those with active bleeding ulcers. The application of an ulcer-covering hemospray is a new promising tool. High dose proton pump inhibitors should be administered intravenously for 72 h in high-risk patients. Helicobacter pylori should be tested for in all patients with peptic ulcer bleeding and eradicated if positive

Su1348 DOPPLER-GUIDED SECOND-LOOK ENDOSCOPY IN PEPTIC ULCER BLEEDING: A RANDOMIZED CONTROLLED TRIAL

2020 ◽  
Vol 158 (6) ◽  
pp. S-559-S-560
Author(s):  
Michael M. Nielsen ◽  
Anders Bo Nielsen ◽  
Ove B. Schaffalitzky de Muckadell ◽  
Stig B. Laursen
Keyword(s):  
Randomized Controlled Trial ◽  
Peptic Ulcer ◽  
Controlled Trial ◽  
Ulcer Bleeding ◽  
Peptic Ulcer Bleeding ◽  
Randomized Controlled ◽  
Second Look
Sign in / Sign up

Export Citation Format

Share Document